2016
DOI: 10.1016/j.jval.2016.09.2004
|View full text |Cite
|
Sign up to set email alerts
|

Systematic Review of Cost-Effectiveness Analysis (CEA) of The Cell Free DNA (CFDNA) / Non-Invasive Prenatal Test (NIPT) for Trisomy 21 (T21) Screening

Abstract: Objectives: Early initiation of antifungal treatment for invasive candidiasis is associated with significant reduction of morality. The process of blood culture is timeconsuming and sensitivity is low for the deep-seated infection. Blood culture-guided treatment is mostly delayed. 1,3-beta-D-glucan (BDG) is one of the components in fungal cell wall and BDG assay is recommended for diagnosis of invasive candidiasis. The objective of this study was to evaluate the potential cost-effectiveness of active BDG surve… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles